Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Spuch

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Brain Communications|September 4, 2024
Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's diseaseAlejandra García-Colomo, David López-Sanz, Cornelis J Stam, et al.
Frontiers in Psychology|January 10, 2022
Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation ProgramMaría Lado-Codesido, Rosa María Rey Varela, Marina Larios Quiñones, et al.
Geroscience|January 3, 2024
Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer's diseaseAlejandra García-Colomo, Alberto Nebreda, Martín Carrasco-Gómez, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 23, 2026
Non-invasive brain stimulation and cognitive training for depressive symptoms and cancer-related cognitive impairment in breast cancer survivors (ONCODEP)Cristina Salgado-Blanco, Jorge Miguel Alcántara Espinosa, Diego Pinal, et al.
Journal of Neuroinflammation|January 18, 2012
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 miceAna María Martín-Moreno, Begoña Brera, Carlos Spuch, et al.
Frontiers in Cellular Neuroscience|May 1, 2015
Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer's Disease PatientsCarlos Spuch, Desireé Antequera, Consuelo Pascual, et al.
BMC Genomics|November 17, 2017
Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOENoriyuki Fuku, Roberto Díaz-Peña, Yasumichi Arai, et al.
Actas Espanolas De Psiquiatria|November 19, 2020
Effectiveness of the “Trisquel” board game intervention program for patients with schizophrenia spectrum disordersAdolfo Pinón-Blanco, Esperanza Vergara-Moragues, Rafael Fernández-Martínez, et al.
Frontiers in Psychiatry|January 22, 2025
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocolSergi Mas, Laura Julià, Manuel J Cuesta, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 1, 2018
The role of the gut microbiota in schizophrenia: Current and future perspectivesDaniela Rodrigues-Amorim, Tania Rivera-Baltanás, Benito Regueiro, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Brain Communications|September 4, 2024
Minimum spanning tree analysis of unimpaired individuals at risk of Alzheimer's diseaseAlejandra García-Colomo, David López-Sanz, Cornelis J Stam, et al.
Frontiers in Psychology|January 10, 2022
Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation ProgramMaría Lado-Codesido, Rosa María Rey Varela, Marina Larios Quiñones, et al.
Geroscience|January 3, 2024
Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer's diseaseAlejandra García-Colomo, Alberto Nebreda, Martín Carrasco-Gómez, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 23, 2026
Non-invasive brain stimulation and cognitive training for depressive symptoms and cancer-related cognitive impairment in breast cancer survivors (ONCODEP)Cristina Salgado-Blanco, Jorge Miguel Alcántara Espinosa, Diego Pinal, et al.
Journal of Neuroinflammation|January 18, 2012
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 miceAna María Martín-Moreno, Begoña Brera, Carlos Spuch, et al.
Frontiers in Cellular Neuroscience|May 1, 2015
Soluble Megalin is Reduced in Cerebrospinal Fluid Samples of Alzheimer's Disease PatientsCarlos Spuch, Desireé Antequera, Consuelo Pascual, et al.
BMC Genomics|November 17, 2017
Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOENoriyuki Fuku, Roberto Díaz-Peña, Yasumichi Arai, et al.
Actas Espanolas De Psiquiatria|November 19, 2020
Effectiveness of the “Trisquel” board game intervention program for patients with schizophrenia spectrum disordersAdolfo Pinón-Blanco, Esperanza Vergara-Moragues, Rafael Fernández-Martínez, et al.
Frontiers in Psychiatry|January 22, 2025
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocolSergi Mas, Laura Julià, Manuel J Cuesta, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 1, 2018
The role of the gut microbiota in schizophrenia: Current and future perspectivesDaniela Rodrigues-Amorim, Tania Rivera-Baltanás, Benito Regueiro, et al.
Pageof 7